Keith Benkov

Icahn School of Medicine at Mount Sinai — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.6kcitations166works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(58), Microscopic Colitis(36), Adolescent and Pediatric Healthcare(18), Autoimmune and Inflammatory Disorders Research(15), Eosinophilic Esophagitis(13)

Publications166 total

HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.
UNC Libraries·2025Open Access
Irritable Bowel Syndrome With Diarrhea in Pediatric Patients Is Associated With Type 2 and Type 9 T Cells in the Intestinal Mucosa
Cellular and Molecular Gastroenterology and Hepatology·2025· 1 citedOpen Access
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease
The American Journal of Gastroenterology·2024· 5 cited
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn’s Disease
Inflammatory Bowel Diseases·2024· 3 cited
Differential T follicular helper cell phenotypes distinguish IgE-mediated milk allergy from eosinophilic esophagitis in children
Journal of Allergy and Clinical Immunology·2024· 5 citedOpen Access
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn’s Disease
The American Journal of Gastroenterology·2024· 10 citedOpen Access
Comparing the Safety and Effectiveness of Medicines to Treat Crohn’s Disease in Children and Adolescents – The COMBINE Trial
2023Open Access
Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn’s Disease: A Pragmatic Randomized Trial
Gastroenterology·2023· 39 citedOpen Access
Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial
SSRN Electronic Journal·2023· 8 citedOpen Access
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn’s disease
Current Medical Research and Opinion·2022
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease
Journal of Pediatric Gastroenterology and Nutrition·2022· 13 citedOpen Access
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
Crohn s & Colitis 360·2022· 3 citedOpen Access
Butanol Purified Food Allergy Herbal Formula-2 Has an Immunomodulating Effect ex-vivo in Pediatric Crohn's Disease Subjects
Frontiers in Medicine·2021· 1 citedOpen Access
Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures as Clinical Trial Endpoints: Experience from a Multicenter Pragmatic Trial in Children with Crohn’s Disease
The Journal of Pediatrics·2021· 7 citedOpen Access
UNDERSTANDING REAL-WORLD BIOLOGIC MAINTENANCE DOSING PATTERNS AMONG PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS
Gastroenterology·2021
DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY
Gastroenterology·2021
TREATMENT PATTERNS OF NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS IN THE IMPROVECARENOW REGISTRY
Gastroenterology·2021
DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY
Inflammatory Bowel Diseases·2021Open Access
TREATMENT PATTERNS OF NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS IN THE IMPROVECARENOW REGISTRY
Inflammatory Bowel Diseases·2021
UNDERSTANDING REAL-WORLD BIOLOGIC MAINTENANCE DOSING PATTERNS AMONG PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS
Inflammatory Bowel Diseases·2021
page 1 of 9Next →

Frequent Co-authors

Neal S. LeLeiko(19), Joel R. Rosh(11), Nanci Pittman(10), Clare Ceballos(8), Jeffrey S. Hyams(7), Michael D. Kappelman(7), Marla C. Dubinsky(7), Laura C. Reigada(7), Jennifer Strople(6), David Dunkin(6), Joanne Lai(6), Anne M. Griffiths(5), James Markowitz(5), Ashish Patel(5), Melvin B. Heyman(5), Joshua D. Noe(5), Prateek Wali(5), Dedrick E. Moulton(5), Carrie Masia Warner(5), Ruijun Bao(5)